Vertex Pharmaceuticals (VRTX) Non-cash Items (2010 - 2011)
Vertex Pharmaceuticals' quarterly Non-cash Items came in at $12.2 million in Q4 2011, down 89.48% year-on-year from $116.2 million in Q4 2010, and down 89.48% quarter-over-quarter from $116.2 million in Q4 2010.
Vertex Pharmaceuticals has reported Non-cash Items for 2 years, with the latest figure at $12.2 million in Q4 2011.
- For the quarter ending Q4 2011, Non-cash Items fell 89.48% year-over-year to $12.2 million; the trailing twelve-month figure through Dec 2011 stood at $12.2 million (down 89.48% YoY), and the FY2011 full-year result was $12.2 million, down 89.48% from the prior year.
- Non-cash Items for Q4 2011 stood at $12.2 million, down from $116.2 million in the prior quarter.
- The five-year high for Non-cash Items was $116.2 million in Q4 2010, with the low at $12.2 million in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 12.23 Mn |
| Dec 31, 2011 | 12.23 Mn |
| Dec 31, 2010 | 116.21 Mn |
| Dec 31, 2010 | 116.21 Mn |